| FDC  Back to Balance Sheet | 
FDC Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹550 Cr | ₹615 Cr | ₹730 Cr | ₹690 Cr | ₹622 Cr | 
What is the latest Total Current Liabilities ratio of FDC ?
| Year | Total Current Liabilities | 
|---|---|
| Mar2025 | ₹550 Cr | 
| Mar2024 | ₹615 Cr | 
| Mar2023 | ₹730 Cr | 
| Mar2022 | ₹690 Cr | 
| Mar2021 | ₹622 Cr | 
How is Total Current Liabilities of FDC Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹550 Cr | -10.54 | |
| Mar2024 | ₹615 Cr | -15.68 | |
| Mar2023 | ₹730 Cr | 5.67 | |
| Mar2022 | ₹690 Cr | 11.03 | |
| Mar2021 | ₹622 Cr | - | |
Compare Total Current Liabilities of peers of FDC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FDC | ₹7,172.2 Cr | 0.7% | -3% | -16.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹411,822.0 Cr | 1.6% | 8.2% | -8.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,811.0 Cr | -0.8% | 14.4% | 12.2% | Stock Analytics | |
| CIPLA | ₹127,688.0 Cr | -3.9% | 5.5% | 5.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,840.0 Cr | -0.5% | 1% | 7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,544.0 Cr | -2.1% | -0% | -2% | Stock Analytics | |
FDC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year | 
| FDC | 0.7% | -3% | -16.3% | 
| SENSEX | 0.7% | 4.7% | 6.1% | 
You may also like the below Video Courses
 
                     
                                     
                                     
                                    